Julian BURSZTYKA

Sales Specialist · PerkinElmer · company speakers →

After Pharmacy studies, Julian got a PhD in Toxicology in 2008, at the INRAE, under the supervision of Jean-Pierre Cravedi. He then moved to the private sector where he held different positions, specializing into evaluating the safety of drugs and cosmetics, using and developing in vitro methods. In 2014, he cofounded HCS Pharma together with Nathalie Maubon, beginning his journey through the almost endless possibilities offered by High Content Screening technics. After 4 Years spent developing his own expertise as well as the know-how of his team, he left and joined PerkinElmer soon after as a Sales Specialist responsible of the High Content Screening portfolio for the French territory. Beside selling HCS systems, Julian is also aiming at developing relationships and partnerships to ensure that the PerkinElmer’s solutions keep their adequation with the needs of his customers who are researchers and engineers in private companies as well as in academia.

pharma-biotechartificial-intelligencedigital-transformation

Is this you? Claim this profile →

No public contact links on file.

Speaking history

Advanced Fermentation Technology (AFT)

30 June 2026 Villeneuve-d'Ascq, France

Topics this speaker covers

pharma-biotechartificial-intelligencedigital-transformation

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →